Melrilimab, CAS 2222865-46-3

Product Description: Melrilimab (GSK 3772847) is an IgG2-kappa anti-IL1RL1/ST2/IL33R/DER4/FIT-1 monoclonal antibody. Melrilimab can be used for the research of asthma[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 35, No. 1, 2021 Recommended INN: List 85.

CAS Number: 2222865-46-3

Molecular Weight: N/A

Compound Purity: 96.07

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Interleukin Related

• SKU: MEXHY-P99729-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99729-10
• Package Unit: 10 mg
• Quantity Unit: STK
• Conjugate: Unconjugated